Mahamud A G M Sofi Uddin, Tanvir Ishtiak Ahammed, Kabir Md Ehsanul, Samonty Ismam, Chowdhury Md Anamul Hasan, Rahman Md Ashikur
Department of Microbiology, University of Georgia, Athens, GA, 30602, USA.
Department of Microbiology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Probiotics Antimicrob Proteins. 2025 Mar 3. doi: 10.1007/s12602-025-10501-w.
As unhealthy aging continues to rise globally, there is a pressing need for effective strategies to promote healthy aging, extend health span, and address aging-related complications. Gerobiotics, an emerging concept in geroscience, offers a novel approach to repurposing selective probiotics, postbiotics, and parabiotics to modulate key aging processes and enhance systemic health. This review explores recent advancements in gerobiotics research, focusing on their role in targeting aging hallmarks, regulating longevity-associated pathways, and reducing risks of multiple age-related chronic conditions. Despite their promise, significant challenges remain, including optimizing formulations, ensuring safety and efficacy across diverse populations, and achieving successful clinical translation. Addressing these gaps through rigorous research, well-designed clinical trials, and advanced biotechnologies can establish gerobiotics as a transformative intervention for healthy aging and chronic disease prevention.
随着全球范围内不健康衰老现象持续增加,迫切需要有效的策略来促进健康衰老、延长健康寿命并解决与衰老相关的并发症。老年益生菌学作为老年科学中的一个新兴概念,提供了一种新方法,即重新利用选择性益生菌、后生元及共生元来调节关键衰老过程并增强全身健康。本综述探讨了老年益生菌学研究的最新进展,重点关注其在针对衰老特征、调节长寿相关通路以及降低多种与年龄相关的慢性病风险方面的作用。尽管它们前景广阔,但仍存在重大挑战,包括优化配方、确保在不同人群中的安全性和有效性以及实现成功的临床转化。通过严谨的研究、精心设计的临床试验和先进的生物技术来填补这些空白,可使老年益生菌学成为促进健康衰老和预防慢性病的变革性干预措施。